Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma - Test2 - elhamkhani - TriplyDB

Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma

Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma

http://www.wikidata.org/entity/Q24681972

about

Ubiquitin proteasome system research in gastrointestinal cancer Changes in gene expression associated with aging commonly originate during juvenile growth Neoplasia: the second decade.Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system.A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2 Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma.UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro.Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.Neoplasia: An Anniversary of Progress.Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.A study of UbcH10 expression and its association with recurrence of meningiomas.Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis.

P2860

Q26766683-D47AAD07-DE88-4F71-A78D-D7CFFC18E2E4 Q28748811-3DD6F8FB-44EE-4EB3-AC03-166A866D6BBE Q30484000-0773E7D4-3429-48C6-8BD7-00851CF83A18 Q33760596-B9384544-7A92-41E6-BA2F-21199CC11652 Q34193882-3998378A-547A-42E4-B2C7-A093601CC6A7 Q34469379-5ABB1B35-5C0F-49DF-925D-34C1B76CE2FD Q34669229-DB3C91DD-877B-4C7F-AF49-17D59D6CAA4B Q34839612-A41F540C-EF86-4B36-B573-C17B50052263 Q35048908-CA2B2735-1253-4405-8F0C-86395BBED518 Q35238452-6AD69B3F-E25B-4264-8BC8-DD1BC976392E Q36055579-3D69ACA4-3B57-4857-9080-E053CB776A4C Q36066046-6A6A28A8-6F67-4436-A54D-78A86A1143FD Q36355935-18960806-2D20-4A6B-A244-B26298BDC683 Q36413323-77BDD73D-863C-48BB-898F-4C1F1B7A372F Q36469187-33DBF877-1B9D-477F-8155-8A4F4F1C8274 Q36956211-4818632B-56A3-4293-86FF-9275206EB3D5 Q37133934-209D9939-889A-4340-B066-2F6529438733 Q37205779-97F9B5F4-D1E3-4D8C-BE50-92B980F58A8E Q37305014-1282B0E4-6ADC-4272-998B-A132CC7A611F Q37662326-66A64138-753E-473C-A4E5-96FB38B14FBC Q37665380-146B7D12-CEF0-4EA8-86D8-4E78DC387359 Q37718705-6EE47F6D-A679-40D3-8EF0-9EFB306A2CB0 Q38721719-0397CD7D-765E-49BE-9E25-3BE157375AC5 Q39320437-7319F604-D054-49C9-B458-9F9748D01A41 Q39331942-89CB9292-0969-4F6E-82CE-A6E455ACB167 Q41779182-ACC51E48-E44B-493D-9073-12D6ADF2E2D7 Q44208471-523189D8-969A-4355-870B-E62DB6D11051 Q46932476-979276A8-F3AE-4108-9379-4ED5E41E1A14 Q51556940-8752512A-C623-4678-A6F6-06EA84154E49 Q52724347-304581E0-765D-45F2-8F32-6F538EEC86F6 Q53204970-4A147E68-28AC-4CDD-9F62-9753C0D43948 Q54241791-DF940EB7-0564-4015-9F81-522EAF351B0D Q55024946-E1A2767E-B82B-47C4-B500-E924DDCF5572

P2860

Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma

http://www.wikidata.org/entity/Q24681972

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@ast

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@en

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@nl

type

label

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@ast

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@en

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@nl

prefLabel

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@ast

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@en

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@nl

P1433

Q24681972-93357C8C-E34D-4E34-AAF5-B28859894166

P1476

Q24681972-C9C975F2-48A7-4308-8CC5-D083EE4147F0

P2093

Q24681972-166BA407-69B1-408B-B698-6F8BB670CB50

Q24681972-1C837A56-7280-47C9-A2BF-16830F8E24EF

Q24681972-4AADB9CB-2F6E-45AC-8A4B-BA3FB934E018

Q24681972-59432E91-A53B-4BA7-857B-24C64851EC97

Q24681972-642BE657-11C5-4AB2-BEF9-E2E77CC77305

Q24681972-6D2D7E74-8919-4083-A43F-939BF4B8CB93

Q24681972-714F101B-ED5D-4C39-8B35-E403CE94DAAC

Q24681972-8653458D-DC85-45B1-85FC-6E10861844D4

Q24681972-8BBACF5F-CAAA-4D81-A320-B86A7465C9DC

Q24681972-CFC5E7FA-96A9-405F-B3AE-9E7259AAB91E

P2860

Q24681972-0031820B-98E6-43C2-86B9-FFC1B46392EE

Q24681972-071527B6-BF53-4FF4-9BFC-7BA853888A4D

Q24681972-09C813ED-5ED0-4E15-A1EC-D60E1F4DB449

Q24681972-144ADC21-31FB-4FCF-A9BC-FC719B49AE5B

Q24681972-197A028E-ADC8-4DEF-89A0-4E9FEAC7FBEF

Q24681972-23B44482-6D73-4A63-8ED7-F1E2FA6E88F1

Q24681972-2FB9AC47-5C46-4F96-AC1D-8AF4223D6939

Q24681972-43F74F14-3F6E-4AA6-BD48-FA602BE055EF

Q24681972-4FA43240-527E-4C62-9D2B-F98763126495

Q24681972-5DD59751-23E4-4C69-AE13-39010E6ED5FA

P304

Q24681972-DC911548-4A71-45D0-BD4F-7145A5F2E171

P31

Q24681972-707AD48D-3415-4FAF-8E8E-270C2470EBD3

P356

Q24681972-08E021E8-6523-472D-9793-DDD41F92B787

P407

Q24681972-4EF2B052-F1B1-48ED-BB40-E97423E24713

P433

Q24681972-C9660940-27AB-4E42-BAC9-8C6FFFF497CD

P478

Q24681972-351A6203-CED7-4780-BF5C-CB5B34984337

P577

Q24681972-FD15D038-EC89-4823-BC6B-F01052038C5D

P5875

Q24681972-40747B47-15DA-4C23-8AF6-26797726C421

P698

Q24681972-C5045F00-7FEB-4181-B6D7-AF54CEE278BA

P921

Q24681972-E11A1E5A-7B5C-4F69-9C64-0EA772831CFF

P932

Q24681972-BB9AC21E-EC6C-4EBB-8C6E-0B32B622A29C

P356

P1433

P1476

Expression and effect of inhib ...... C on esophageal adenocarcinoma

@en

P2093

Andrew C Chang

http://www.w3.org/2001/XMLSchema#string

Dafydd G Thomas

http://www.w3.org/2001/XMLSchema#string

David G Beer

http://www.w3.org/2001/XMLSchema#string

Duna A Raoof

http://www.w3.org/2001/XMLSchema#string

Joel K Greenson

http://www.w3.org/2001/XMLSchema#string

Jules Lin

http://www.w3.org/2001/XMLSchema#string

Lin Lin

http://www.w3.org/2001/XMLSchema#string

Mark B Orringer

http://www.w3.org/2001/XMLSchema#string

Mu-Yen Lin

http://www.w3.org/2001/XMLSchema#string

Thomas J Giordano

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase

Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10

Summaries of Affymetrix GeneChip probe level data

How proteolysis drives the cell cycle

The ubiquitin-proteasome proteolytic pathway

Tissue microarrays for high-throughput molecular profiling of tumor specimens

UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.

Control of DNA replication and chromosome ploidy by geminin and cyclin A

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.

Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH.

P304

1062-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.05832

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6583263

http://www.w3.org/2001/XMLSchema#string

P698

17217624

http://www.w3.org/2001/XMLSchema#string

P921

P932

1783715

http://www.w3.org/2001/XMLSchema#string